Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2019

Open Access 01-12-2019 | Influenza | Research article

Experimental validation and computational modeling of anti-influenza effects of quercetin-3-O-α-L-rhamnopyranoside from indigenous south African medicinal plant Rapanea melanophloeos

Authors: Parvaneh Mehrbod, Samad Nejad Ebrahimi, Fatemeh Fotouhi, Fatemeh Eskandari, Jacobus N. Eloff, Lyndy J. McGaw, Folorunso O. Fasina

Published in: BMC Complementary Medicine and Therapies | Issue 1/2019

Login to get access

Abstract

Background

Influenza A virus (IAV) is still a major health threat. The clinical manifestations of this infection are related to immune dysregulation, which causes morbidity and mortality. The usage of traditional medication with immunomodulatory properties against influenza infection has been increased recently. Our previous study showed antiviral activity of quercetin-3-O-α-L-rhamnopyranoside (Q3R) isolated from Rapanea melanophloeos (RM) (L.) Mez (family Myrsinaceae) against H1N1 (A/PR/8/34) infection. This study aimed to confirm the wider range of immunomodulatory effect of Q3R on selective pro- and anti-inflammatory cytokines against IAV in vitro, to evaluate the effect of Q3R on apoptosis pathway in combination with H1N1, also to assess the physical interaction of Q3R with virus glycoproteins and RhoA protein using computational docking.

Methods

MDCK cells were exposed to Q3R and 100CCID50/100 μl of H1N1 in combined treatments (co-, pre- and post-penetration treatments). The treatments were tested for the cytokines evaluation at RNA and protein levels by qPCR and ELISA, respectively. In another set of treatment, apoptosis was examined by detecting RhoA GTPase protein and caspase-3 activity. Molecular docking was used as a tool for evaluation of the potential anti-influenza activity of Q3R.

Results

The expressions of cytokines in both genome and protein levels were significantly affected by Q3R treatment. It was shown that Q3R was much more effective against influenza when it was applied in co-penetration treatment. Q3R in combination with H1N1 increased caspase-3 activity while decreasing RhoA activation. The molecular docking results showed strong binding ability of Q3R with M2 transmembrane, Neuraminidase of 2009 pandemic H1N1, N1 and H1 of PR/8/1934 and Human RhoA proteins, with docking energy of − 10.81, − 10.47, − 9.52, − 9.24 and − 8.78 Kcal/mol, respectively.

Conclusions

Quercetin-3-O-α-L-rhamnopyranoside from RM was significantly effective against influenza infection by immunomodulatory properties, affecting the apoptosis pathway and binding ability to viral receptors M2 transmembrane and Neuraminidase of 2009 pandemic H1N1 and human RhoA cellular protein. Further research will focus on detecting the detailed specific mechanism of Q3R in virus-host interactions.
Literature
1.
Rolfes MA, Foppa IM, Garg S, Flannery B, Brammer L, Singleton JA, et al. Annual estimates of the burden of seasonal influenza in the United States: a tool for strengthening influenza surveillance and preparedness. Influenza Other Resp. 2018;12(1):132–7.CrossRef
2.
Thompson MG, Shay DK, Zhou H, Bridges CB, Cheng PY, Burns E, et al. Estimates of deaths associated with seasonal influenza - United States, 1976-2007. MMWR-Morbid Mortal W. 2010;59(33):1057–62.
3.
Haidari M, Zhang W, Ganjehei L, Muzammil A, Zhenping C. Inhibition of MLC phosphorylation restricts replication of influenza virus-a mechanism of action for anti-influenza agents. PLoS One. 2011;6(6):e21444.PubMedPubMedCentralCrossRef
4.
Whittaker GR. Intracellular trafficking of influenza virus: clinical implications for molecular medicine. Expert Rev Mol Med. 2001;3:1–13.CrossRef
5.
Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit Care Med. 2010;38:e91–e7.PubMedCrossRef
6.
de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, et al. Fatal outcome of human influenza a (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006;12:1203.PubMedPubMedCentral
7.
Perrone LA, Szretter KJ, Katz JM, Mizgerd JP, Tumpey TM. Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus. J Infect Dis. 2010;202(8):1161–70.PubMedCrossRef
8.
Tavares LP, Teixeira MM, Garcia CC. The inflammatory response triggered by influenza virus: a two edged sword. Inflamm Res. 2017;66(4):283–302.PubMedCrossRef
9.
Hendrickson CM, Matthay MA. Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic. Semin Resp Crit Care M. 2013;34(4):475–86.CrossRef
10.
Bruder D, Srikiatkhachorn A, Enelow RI. Cellular immunity and lung injury in respiratory virus infection. Viral Immunol. 2006;19(2):147–55.PubMedCrossRef
11.
Mehrbod P, Hair-Bejo M, Tengku Ibrahim TA, Omar AR, El Zowalaty M, Ajdari Z, et al. Simvastatin modulates cellular components in influenza a virus-infected cells. Int J Mol Med. 2014;34:61–73.PubMedPubMedCentralCrossRef
12.
Mehrbod P, El Zowalaty M, Omar AR, Hair-Bejo M, Ideris A. Statins reduce the expression of proinflammatory cytokines in influenza a virus infected CrFK cells. Acta Virol. 2012;56(4):353–5.PubMedCrossRef
13.
Khalafalla MM, Abdellatef E, Dafalla HM, Nassrallah AA, Aboul-Enein KM, Lightfoot DA, et al. Active principle from moringa oleifera lam leaves effective against two leukemias and a hepatocarcinoma. Afr J Biotechnol. 2010;9(49):8467–71.
14.
Mozaffari Nejad AS, Kamkar A, Giri A, Pourmahmoudi AA. Ethnobotany and folk medicinal uses of major trees and shrubs in northern Iran. J Med Plant Res. 2013;7(7):284–9.
15.
Amic D, Amie DD, Beslo D, Trinajstic N. Structural-radical scavenging activity relationship of flavonoids. Croat Chem Acta. 2003;76:55–61.
16.
Aqil F, Ahmad I, Mehmood Z. Antioxidant and free radical scavenging properties of twelve traditionally used Indian medicinal plants. Turk J Biol. 2006;30:177–83.
17.
Jalali H, Mozaffari Nejad AS, Ebadi AG, Laey G. Ethnobotany and folk pharmaceutical properties of major trees or shrubs in northeast of Iran. Asian J Chem. 2009;21(7):5632–8.
18.
Mehrbod P, Ideris A, Omar AR, Hair-Bejo M. Prophylactic effect of herbal-marine compound (HESA-A) on influenza a virus infectivity. BMC Complem Altern M. 2014;14(1):131.CrossRef
19.
20.
Zhang W, Du L, Gunst SJ. The effects of the small GTPase RhoA on the muscarinic contraction of airway smooth muscle result from its role in regulating actin polymerization. Am J Physiol-Cell Physiol. 2010;299:C298–306.PubMedPubMedCentralCrossRef
21.
Hall A. Rho GTPases and the control of cell behaviour. Biochem Soc T. 2005;33:891–5.CrossRef
22.
Wang J, Li H, Chen Y, Wei H, Gao GF, Liu H, et al. Transport of influenza virus neuraminidase (NA) to host cell surface is regulated by ARHGAP21 and Cdc42 proteins. J Biol Chem. 2012;287(13):9804–16.PubMedPubMedCentralCrossRef
23.
Bishop AL, Hall A. Rho GTPases and their effector proteins. Biochem J. 2000;1(348):241–55.CrossRef
24.
Ridley AJ. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol. 2006;16(10):522–9.PubMedCrossRef
25.
Hippenstiel S, Schmeck B, N'Guessan PD, Seybold J, Krüll M, Preissner K, et al. Rho protein inactivation induced apoptosis of cultured human endothelial cells. Am J Physiol-Lung Cell Mol Physiol. 2002;283(4):L830–L8.PubMedCrossRef
26.
Esteve P, Embade N, Perona R, Jiménez B, del Peso L, León J, et al. Rho-regulated signals induce apoptosis in vitro and in vivo by a p53-independent, but Bcl2 dependent pathway. Oncogene. 1998;17(14):1855–69.PubMedCrossRef
27.
28.
29.
Lai WW, Hsu SC, Chueh FS, Chen YY, Yang JS, Lin JP, et al. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/−9 signaling pathways. Anticancer Res. 2013;33(5):1941–50.PubMed
30.
Schroeter H, Spencer JP, Rice-Evans C, Williams RJ. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J. 2001;358(Pt 3):547–57.PubMedPubMedCentralCrossRef
31.
Kaul TN, Middleton E, Ogra PL. Antiviral effect of flavonoids on human viruses. J Med Virol. 1985;15(1):71–9.PubMedCrossRef
32.
Orhan DD, Özçelik B, Özgen S, Ergun F. Antibacterial, antifungal, and antiviral activities of some flavonoids. Microbiol Res. 2010;165(6):496–504.PubMedCrossRef
33.
Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, AbuBakar S. Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol J. 2011;8(1):560.PubMedPubMedCentralCrossRef
34.
Kumar S, Pandey AK. Chemistry and biological activities of Fflavonoids: an overview. Sci World J. 2013;2013:1–16.
35.
Johari J, Kianmehr A, Mustafa RM, Abubakar S, Zandi K. Antiviral activity of baicalein and quercetin against the Japanese encephalitis virus. Int J Mol Sci. 2012;13(12):16785–95.PubMedPubMedCentralCrossRef
36.
37.
Ramos FA, Takaishi Y, Shirotori M, Kawaguchi Y, Tsuchiya K, Shibata H, et al. Antibacterial and antioxidant activities of quercetin oxidation products from yellow onion (Allium cepa) skin. J Agric Food Chem. 2006;54(10):3551–7.PubMedCrossRef
38.
Li BQ, Fu T, Dongyan Y, Mikovits JA, Ruscetti FW, Wang JM. Flavonoid Baicalin inhibits HIV-1 infection at the level of viral entry. Biochem Bioph Res Co. 2000;276(2):534–8.CrossRef
39.
Anusuya S, Gromiha MM. Quercetin derivatives as non-nucleoside inhibitors for dengue polymerase: molecular docking, molecular dynamics simulation, and binding free energy calculation. J Biomol Struct Dyn. 2017;35(13):2895–909.PubMedCrossRef
40.
Rojas Á, Del Campo JA, Clement S, Lemasson M, García-Valdecasas M, Gil-Gómez A, et al. Effect of Quercetin on hepatitis C virus life cycle: From viral to Host targets. Sci Rep. 2016;6:31777.PubMedPubMedCentralCrossRef
41.
Wong G, He S, Siragam V, Bi Y, Mbikay M, Chretien M, et al. Antiviral activity of quercetin-3-β-O-D-glucoside against Zika virus infection. Virol Sin. 2017;32(6):545–7.PubMedPubMedCentralCrossRef
42.
Hafidh RR, Abdulamir AS, Jahanshiri F, Abas F, Abu Bakar F, Sekawi Z. Asia is the mine of natural antiviral products for public health. Open Complem Med J. 2009;1:58–68.
43.
Dayem AA, Choi HY, Kim YB, Cho SG. Antiviral effect of methylated flavonol isorhamnetin against influenza. PLoS One. 2015;10(3):e0121610.PubMedCentralCrossRef
44.
Hossain MK, Choi HY, Hwang JS, Dayem AA, Kim JH, Kim YB, et al. Antiviral activity of 3,4′-dihydroxyflavone on influenza a virus. J Microbiol. 2014;52(6):521–6.PubMedCrossRef
45.
Arena A, Bisignano G, Pavone B, Tomaino A, Bonina FP, Saija A, et al. Antiviral and immunomodulatory effect of a lyophilized extract of Capparis spinosa L. buds. Phytother Res. 2008;22(3):313–7.PubMedCrossRef
46.
Chiang LC, Ng LT, Chiang W, Chang MY, Lin CC. Immunomodulatory activities of flavonoids, monoterpenoids, triterpenoids, iridoid glycosides and phenolic compounds of Plantago species. Planta Med. 2003;69(7):600–4.PubMedCrossRef
47.
Aichour R, Charef N, Baghiani A, Arrar L. Immunomodulatory effects of Algerian caper. Int J Pharm Pharm Sci. 2016;8(2):51–4.
48.
Miles SL, McFarland M, Niles RM. Molecular and physiological actions of quercetin: need for clinical trials to assess its benefits in human disease. Nutr Rev. 2014;72(11):720–34.PubMedCrossRef
49.
Wu W, Li R, Li X, He J, Jiang S, Liu S, et al. Quercetin as an antiviral agent inhibits influenza a virus (IAV) entry. Viruses. 2016;8(1):6.CrossRef
50.
Choi HJ, Song JH, Park KS, Kwon DH. Inhibitory effects of quercetin 3-rhamnoside on influenza a virus replication. Eur J Pharm Sci. 2009;37(3):329–33.PubMedCrossRef
51.
Lakhanpal P, Rai DK. Quercetin: A versatile flavonoid. Internet J Medic Update. 2007;2:22–37.
52.
53.
Chun OK, Chung SJ, Claycombe KJ, Song WO. Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S. adults. J Nutr. 2008;138(4):753–60.PubMedCrossRef
54.
Mehrbod P, Abdalla MA, Fotouhi F, Heidarzadeh M, Aro AO, Eloff JN, et al. Immunomodulatory properties of quercetin-3-O-α-L-rhamnopyranoside from Rapanea melanophloeos against influenza a virus. BMC Complem Altern M. 2018;18(1):184.CrossRef
55.
Mehrbod P, Abdalla MA, Njoya EM, Ahmed AS, Fotouhi F, Farahmand B, et al. South African medicinal plant extracts active against influenza a virus. BMC Complem Altern M. 2018;18(1):112.CrossRef
56.
Bradford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.CrossRefPubMed
57.
Liu Z, Zhao J, Li W, Shen L, Huang S, Tang J, et al. Computational screen and experimental validation of anti-influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine. Sci Rep. 2016;6:19095.PubMedPubMedCentralCrossRef
58.
Zhang Y, Han H, Qiu H, Lin H, Yu L, Zhu W, et al. Antiviral activity of a synthesized shikonin ester against influenza a (H1N1) virus and insights into its mechanism. Biomed Pharmacother. 2017;93:636–45.PubMedCrossRef
59.
60.
Haghani A, Mehrbod P, Safi N, Aminuddin NA, Bahadoran A, Omar AR, et al. In vitro and in vivo mechanism of immunomodulatory and antiviral activity of edible Bird's Nest (EBN) against influenza a virus (IAV) infection. J Ethnopharmacol. 2016;185:327–40.PubMedCrossRef
61.
Kozak W, Poli V, Soszynski D, Conn CA, Leon LR, Kluger MJ. Sickness behavior in mice mice deficient in interleukin-6 during turpentine abcess and influenza pneumonitis. Am J Phys. 1997;272:R621–R30.
62.
Egecioglu E, Anesten F, Schéle E, Palsdottir V. Interleukin-6 is important for regulation of core body temperature during long-term cold exposure in mice. Biomed Rep. 2018;9(3):206–12.PubMedPubMedCentral
63.
Svitek N, Rudd PA, Obojes K, Pillet S, von Messling V. Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction. Virology. 2008;376(1):53–9.PubMedCrossRef
64.
Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. CCL2. P Natl Acad Sci USA. 1994;91:3652–6.CrossRef
65.
Herold S, Steinmueller M, von Wulffen W, Cakarova L, Pinto R, Pleschka S, et al. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med. 2008;205(13):3065–77.PubMedPubMedCentralCrossRef
66.
Lee N, Wong CK, Chan PK, Lindegardh N, White NJ, Hayden FG, et al. Acute encephalopathy associated with influenza a infection in adults. Emerg Infect Dis. 2010;16(1):139–42.PubMedPubMedCentralCrossRef
67.
Aldridge JR, Moseley CE, Boltz DA, Negovetich NJ, Reynolds C, Franks J, et al. From the cover: TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. P Natl Acad Sci USA. 2009;106:5306–11.CrossRef
68.
Billiau A. Interferon beta in the cytokine network: an anti-inflammatory pathway. Mult Scler J. 1995;1(1):S2–4.CrossRef
69.
Kasper LH, Reder AT. Immunomodulatory activity of interferon-beta. Ann Clin Transl Neur. 2014;1(8):622–31.CrossRef
70.
Donelan NR, Basler CF, García-Sastre A. A recombinant influenza a virus expressing an RNA-binding-defective NS1 protein induces high levels of Beta interferon and is attenuated in mice. J Virol. 2003;77(24):13257–66.PubMedPubMedCentralCrossRef
71.
Liu D, Mei X, Wang L, Yang X. RhoA inhibits apoptosis and increases proliferation of cultured SPCA1 lung cancer cells. Mol Med Rep. 2017;15(6):3963–8.PubMedPubMedCentralCrossRef
72.
Kim YJ, Jung EB, Seo SJ, Park KH, Lee MW, Lee CS. Quercetin-3-O-(2″-galloyl)-α-l-rhamnopyranoside prevents TRAIL-induced apoptosis in human keratinocytes by suppressing the caspase-8- and bid-pathways and the mitochondrial pathway. Chem Biol Interact. 2013;204(3):144–q52.PubMedCrossRef
73.
Han H, Xu B, Amin A, Li H, Yu X, Gong M, et al. Quercetin3OαLrhamnopyranoside derived from the leaves of Lindera aggregata (Sims) Kosterm. Evokes the autophagyinduced nuclear factor erythroid 2related factor 2 antioxidant pathway in human umbilical vein endothelial cells. Int J Mol Med. 2019;43(1):461–74.PubMed
Metadata
Title
Experimental validation and computational modeling of anti-influenza effects of quercetin-3-O-α-L-rhamnopyranoside from indigenous south African medicinal plant Rapanea melanophloeos
Authors
Parvaneh Mehrbod
Samad Nejad Ebrahimi
Fatemeh Fotouhi
Fatemeh Eskandari
Jacobus N. Eloff
Lyndy J. McGaw
Folorunso O. Fasina
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2019
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-019-2774-3

Other articles of this Issue 1/2019

BMC Complementary Medicine and Therapies 1/2019 Go to the issue

Research article

Improvement of diabetic wound healing by topical application of Vicenin-2 hydrocolloid film on Sprague Dawley rats

Research article

Icariin-conditioned serum engineered with hyaluronic acid promote repair of articular cartilage defects in rabbit knees

Research article

The mycelium of the Trametes versicolor (Turkey tail) mushroom and its fermented substrate each show potent and complementary immune activating properties in vitro

Research article

Anti-inflammatory, analgesic and acute toxicity effects of fermented soybean

Research article

Oolong tea consumption and its interactions with a novel composite index on esophageal squamous cell carcinoma

Research article

Characterization, evaluation of nutritional parameters of Radix isatidis protein and its antioxidant activity in D-galactose induced ageing mice